Importantly, we previously described a correlation between higher CSF MCP-1 levels and faster cognitive decline in prodromal AD patients despite no significant differences in MCP-1 levels compared to controls at baseline[31]. The gene discussed is CCL2; the disease is Alzheimer disease.